BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc. financial statements

BridgeBio Oncology Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 134.04M10-K
Cash and equivalentsUSD 373.69M10-Q
Total debtUSD 2.77MEODHD

BridgeBio Oncology Therapeutics, Inc. financials on 6ix · BridgeBio Oncology Therapeutics, Inc. on 6ix